大洋生物(003017.SZ)股东汪贤高拟减持不超57万股

Core Viewpoint - The major shareholder of Dayang Bio (003017.SZ), Wang Xiangao, plans to reduce his stake in the company by selling up to 570,000 shares, which represents 0.68% of the total shares outstanding, within a specified period [1] Summary by Sections - Shareholder Reduction Plan - Wang Xiangao intends to sell up to 570,000 shares of Dayang Bio, starting from January 12, 2026, to April 11, 2026, excluding any periods where selling is prohibited by regulatory authorities [1] - Regulatory Compliance - The share reduction will be conducted through centralized bidding, adhering to the regulations set forth by the China Securities Regulatory Commission or the Shenzhen Stock Exchange [1]